Americans for Safe Access |
Now, the battle over rescheduling has moved from DEA and HHS to the federal courts. |
“The DEA had ignored accumulating evidence of marijuana’s benefits, and so acted “arbitrarily and capriciously” in rejecting the rescheduling petition last year. Federal law requires the agency to take such evidence into account, accusing the Department of Health and Human Services of creating a Catch-22 for medical marijuana advocates by strictly limiting researchers’ access to marijuana, then arguing there is insufficient scientific evidence to merit rescheduling it.”
The present day drug scheduling is an incomplete scale in that it only lists negatives!
Medical marijuana does not fit into the present drug schedule; this unique medicine is so special that its multitude of many actions creates its own stand-alone category, a “positive side,” mirror-image type of drug scheduling.